Levothyroxine supply not impacted by US recall: TGA

Products impacted by the FDA’s recall of levothyroxine sodium tablets are limited to those distributed in the US, a TGA spokesperson says  Pharmacists are being advised that patients taking levothyroxine sodium tablets in Australia will not be impacted the US Food and Drug Administration's (FDA) recall of a number of batches of the medication. Following